Fmr LLC Sells 2,380,516 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Fmr LLC decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 7.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 30,120,629 shares of the healthcare conglomerate's stock after selling 2,380,516 shares during the quarter. UnitedHealth Group makes up 0.9% of Fmr LLC's holdings, making the stock its 14th biggest position. Fmr LLC owned about 3.27% of UnitedHealth Group worth $15,236,821,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of UNH. NewSquare Capital LLC acquired a new position in UnitedHealth Group in the 4th quarter valued at $25,000. Hurley Capital LLC bought a new stake in UnitedHealth Group in the 4th quarter valued at about $28,000. AlphaMark Advisors LLC bought a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $30,000. Aster Capital Management DIFC Ltd bought a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $30,000. Finally, Promus Capital LLC acquired a new position in UnitedHealth Group in the 4th quarter valued at $32,000. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $524.94 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The business has a 50-day simple moving average of $509.24 and a 200 day simple moving average of $542.12. The firm has a market capitalization of $480.17 billion, a price-to-earnings ratio of 33.87, a PEG ratio of 1.37 and a beta of 0.62.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the previous year, the firm posted $5.83 earnings per share. The firm's revenue for the quarter was up 6.8% on a year-over-year basis. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.60%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's payout ratio is currently 54.19%.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction on Friday, January 17th. The shares were acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 0.33% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on UNH. HSBC upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 target price for the company in a research report on Friday, January 10th. Piper Sandler decreased their target price on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a research report on Thursday, January 2nd. Truist Financial reduced their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a research note on Monday, January 6th. Wells Fargo & Company dropped their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a research note on Tuesday, January 28th. Finally, Cantor Fitzgerald restated an "overweight" rating and set a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Twenty investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Buy" and a consensus target price of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.